ARCHIVES

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

This article is from The Cancer Letter archive.

Vol. 20 No. 33 | August 19, 1994

Download PDF Visit The Full Archive

Related Articles

ONS Backs Independent Nursing Research, Splits From ASCO On Meetings

September 3, 1982

Season’s Greetings from the Cancer Letter

December 17, 1999

Mentholated Cigarettes Cause No More Lung Cancer, Deaths

March 25, 2011

Letter: Headline Criticized On Letter About Consortium

June 21, 1996

HHS Inquiry Triggers Sloppy Stories On Gallo’s Laboratory

July 21, 1989

Shalala Named President, University Of Miami.

November 24, 2000